Efficacy News and Research

RSS
YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation

YM BioSciences' CYT387 receives European Commission positive opinion for Orphan Drug Designation

Radiant to expand consumer products testing capabilities

Radiant to expand consumer products testing capabilities

Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure

Takeda, Affymax submit peginesatide NDA to FDA for treatment of anemia linked with chronic renal failure

YM announces updates on nimotuzumab clinical development program

YM announces updates on nimotuzumab clinical development program

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

New positive Cimzia phase IIIb study data on rheumatoid arthritis presented at EULAR meeting

Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea

Optimer receives FDA approval for Dificid tablets to treat C. difficile-associated diarrhea

Efficacy of Abbott cholesterol drug in question

Efficacy of Abbott cholesterol drug in question

D3 Oncology Solutions provides six-month free trial period for Via Oncology Pathways program

D3 Oncology Solutions provides six-month free trial period for Via Oncology Pathways program

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

NHLBI stops AIM-HIGH combination clinical trial in high blood cholesterol

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

4SC to present pre-clinical data on vidofludimus in systemic lupus erythematosus at EULAR 2011

Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice

Positive results from CEL-SCI's LEAPS H1N1-activated dendritic cells trial in mice

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

Neurologix presents NLX-P101 Phase 2 trial in Parkinson's disease at 10th INS World Congress

MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adults

MAP Pharmaceuticals submits LEVADEX NDA to FDA for treatment of migraine in adults

BioCryst presents positive data from two BCX4208 Phase 2 studies in gout at EULAR 2011

BioCryst presents positive data from two BCX4208 Phase 2 studies in gout at EULAR 2011

Study evaluates effectiveness of systems training for emotion control in 'real world' patients with BPD

Study evaluates effectiveness of systems training for emotion control in 'real world' patients with BPD

New Hypertension Management Program study results revealed at ASH scientific meeting

New Hypertension Management Program study results revealed at ASH scientific meeting

Tofacitinib safe and effective for patients with rheumatoid arthritis

Tofacitinib safe and effective for patients with rheumatoid arthritis

Precision ophthalmic tint lenses reduce migraine, study shows

Precision ophthalmic tint lenses reduce migraine, study shows

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Recent advances in vaccine development for malaria, TB and HIV/AIDS

Scarcity of resources calls for equitable distribution system for novel HCV treatment

Scarcity of resources calls for equitable distribution system for novel HCV treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.